logo

Intec Pharma Ltd. (NTEC)



Trade NTEC now with
  Date
  Headline
8/9/2019 7:16:01 AM Intec Pharma Q2 Loss Per Share $0.30 Vs $0.34 Last Year
7/22/2019 7:05:59 AM Intec Pharma Says ACCORDANCE Study Did Not Achieve Statistical Superiority To Sinemet
6/25/2019 7:03:24 AM Intec Announces Results From Earlier Phase 2 Trial Of Accordion Pill-Carbidopa/Levodopa In Advanced Parkinson's Disease
6/19/2019 7:04:35 AM Intec Pharma Says Results From Pharmacokinetics Study Of AP-CD/LD 50/500 Mg Presented At The XXIV World Congress
5/20/2019 7:46:36 AM Intec Pharma Granted European Patent
5/20/2019 7:00:00 AM Intec Pharma Granted European Patent (Press Release)
5/16/2019 6:04:33 AM Intec Pharma Announces Research Collaboration Agreement With Merck
5/7/2019 7:06:59 AM Intec Pharma Q1 Net Loss Flat At $10.7 Mln
2/27/2019 7:17:08 AM Intec Pharma Q4 Net Loss $12.6 Mln Vs. Net Loss $10.2 Mln Last Year
2/19/2019 7:09:26 AM Intec : AP-CD/LD Met Primary Endpoint Of Reducing Plasma Levodopa Variability Vs. Standard Oral CD/LD With Significance
1/2/2019 7:07:49 AM Intec Pharma Doses First Patient In Phase 1 Pharmacokinetic Study Of AP-THC
12/19/2018 9:30:19 AM  Intec Pharma Reviews 2018 Progress And Provides Outlook For 2019
11/9/2018 7:08:25 AM Intec Pharma 9-month Loss Per Share $1.01 Vs Loss $1.27 Last Year